IGMM, CNRS, Univ. Montpellier, Montpellier, France.
Swiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.
Sci Rep. 2017 Oct 18;7(1):13429. doi: 10.1038/s41598-017-12868-5.
Although cyclin-dependent kinase 2 (Cdk2) controls the G1/S transition and promotes DNA replication, it is dispensable for cell cycle progression due to redundancy with Cdk1. Yet Cdk2 also has non-redundant functions that can be revealed in certain genetic backgrounds and it was reported to promote the G2/M DNA damage response checkpoint in TP53 (p53)-deficient cancer cells. However, in p53-proficient cells subjected to DNA damage, Cdk2 is inactivated by the CDK inhibitor p21. We therefore investigated whether Cdk2 differentially affects checkpoint responses in p53-proficient and deficient cell lines. We show that, independently of p53 status, Cdk2 stimulates the ATR/Chk1 pathway and is required for an efficient DNA replication checkpoint response. In contrast, Cdk2 is not required for a sustained DNA damage response and G2 arrest. Rather, eliminating Cdk2 delays S/G2 progression after DNA damage and accelerates appearance of early markers of cell cycle exit. Notably, Cdk2 knockdown leads to down-regulation of Cdk6, which we show is a non-redundant pRb kinase whose elimination compromises cell cycle progression. Our data reinforce the notion that Cdk2 is a key p21 target in the DNA damage response whose inactivation promotes exit from the cell cycle in G2.
虽然细胞周期蛋白依赖性激酶 2(Cdk2)控制 G1/S 期转换并促进 DNA 复制,但由于与 Cdk1 的冗余,它对于细胞周期进程不是必需的。然而,Cdk2 也具有非冗余功能,这些功能可以在某些遗传背景下显现出来,并且据报道,它可以促进 TP53(p53)缺陷型癌细胞中的 G2/M DNA 损伤反应检查点。然而,在 p53 功能正常的细胞中受到 DNA 损伤时,CDK 抑制剂 p21 使 Cdk2 失活。因此,我们研究了 Cdk2 是否会对 p53 功能正常和缺陷的细胞系中的检查点反应产生不同的影响。我们表明,独立于 p53 状态,Cdk2 可刺激 ATR/Chk1 途径,并且是有效的 DNA 复制检查点反应所必需的。相比之下,Cdk2 对于持续的 DNA 损伤反应和 G2 期阻滞不是必需的。相反,消除 Cdk2 会延迟 DNA 损伤后 S/G2 期的进展,并加速细胞周期退出的早期标志物的出现。值得注意的是,Cdk2 的敲低导致 Cdk6 的下调,我们表明 Cdk6 是一种非冗余的 pRb 激酶,其消除会损害细胞周期进程。我们的数据强化了这样一种观点,即 Cdk2 是 DNA 损伤反应中 p21 的关键靶标,其失活可促进 G2 期细胞周期退出。